INSERM (INSTITUT DE LA SANTE ET DE LA RECHERCHE MEDICALE);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;SORBONNE UNIVERSITE
发明人:
SENNLAUB, FLORIAN,HOUSSET, MICHAEL,GUILLONNEAU, XAVIER,SAHEL, JOSE-ALAIN,KAROYAN, PHILIPPE
申请号：
CA3023802
公开号：
CA3023802A1
申请日:
2017.05.10
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to agents activating CD47 and their use in the treatment of inflammation, in particular non-resolving low grade inflammation, characterized by chronic MP infiltration, such as age-related macular degeneration. The present invention also relates to pharmaceutical compositions, medicaments and kits comprising said agents.
